Cargando…
PKCα is required for Akt-mTORC1 activation in Non-Small Cell Lung Carcinoma (NSCLC) with EGFR mutation
Mutational activation of the epidermal growth factor receptor (EGFR) is a major player in the pathogenesis of non-small cell lung cancer (NSCLC). NSCLC patients with constitutively active EGFR mutations (mEGFR) eventually develop drug resistance against EGFR tyrosine-kinase inhibitors (TKIs); theref...
Autores principales: | Salama, Mohamed F., Liu, Mengling, Clarke, Christopher J., Espaillat, Mel Pilar, Haley, John, Jin, Ting, Wang, Daifeng, Obeid, Lina M., Hannun, Yusuf A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883150/ https://www.ncbi.nlm.nih.gov/pubmed/31420605 http://dx.doi.org/10.1038/s41388-019-0950-z |
Ejemplares similares
-
Co-ordinated activation of classical and novel PKC isoforms is required for PMA-induced mTORC1 activation
por: Liu, Mengling, et al.
Publicado: (2017) -
Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma
por: Ronellenfitsch, Michael W., et al.
Publicado: (2018) -
mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016) -
mTORC2/Akt activation in adipocytes is required for adipose tissue inflammation in tuberculosis
por: Martinez, Nuria, et al.
Publicado: (2019) -
C1orf74 positively regulates the EGFR/AKT/mTORC1 signaling in lung adenocarcinoma cells
por: Guo, Jinyong, et al.
Publicado: (2022)